tibolone has been researched along with Arteriosclerosis, Coronary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anthony, MS; Clarkson, TB; Mikkola, TS; St Clair, RW | 1 |
Demirci, F; Erdogmus, B; Ozdemir, I; Somunkiran, A; Yazici, B | 1 |
Assmann, G; Bennink, HJ; Elbers, J; Gülbahçe, E; Helmond, F; Hövels, A; Schmiddem, K; Schuler-Lüttmann, S; von Eckardstein, A | 1 |
1 trial(s) available for tibolone and Arteriosclerosis, Coronary
Article | Year |
---|---|
Lowering of HDL cholesterol in post-menopausal women by tibolone is not associated with changes in cholesterol efflux capacity or paraoxonase activity.
Topics: Aged; Anabolic Agents; Apolipoprotein A-I; Apolipoprotein A-II; Aryldialkylphosphatase; Cholesterol; Cholesterol, HDL; Coronary Artery Disease; Double-Blind Method; Esterases; Female; Hormone Replacement Therapy; Humans; Middle Aged; Norpregnenes; Postmenopause; Reference Values; Statistics, Nonparametric | 2001 |
2 other study(ies) available for tibolone and Arteriosclerosis, Coronary
Article | Year |
---|---|
Serum cholesterol efflux potential is an independent predictor of coronary artery atherosclerosis.
Topics: Animals; Apolipoprotein A-I; Arteries; Biomarkers; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Coronary Artery Disease; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Estrogen Receptor Modulators; Female; Fibroblasts; Haplorhini; Models, Cardiovascular; Multivariate Analysis; Norpregnenes; Observer Variation; Predictive Value of Tests; Skin; Statistics as Topic; Tunica Intima; Women's Health | 2003 |
Effects of tibolone on blood flow resistance and intima-media thickness of the carotid arteries: effect of time since menopause.
Topics: Carotid Arteries; Cholesterol, HDL; Cholesterol, LDL; Coronary Artery Disease; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Humans; Menopause; Middle Aged; Norpregnenes; Prospective Studies; Pulsatile Flow; Time Factors; Treatment Outcome; Triglycerides; Tunica Intima; Vascular Resistance; Vertebral Artery | 2006 |